logo-mini

About

We can’t solve problems by using the same kind of thinking we used when we created them.

Albert Einstein

We Are Celling Biosciences

Want to learn more?
Contact us

“CELLING” THE NEXT BIG THING

Helping the body heal itself – in a nutshell, that’s the science of regenerative medicine, and for many doctors, it’s the future of their practices. We’re Celling Biosciences, and we offer clinician point-of-care products and therapies to advance the science of healing and redefine the global medical landscape.

Our products provide physicians options when they decide to tap into a patient’s capacity for native healing by harvesting cells from the body, processing them and then re-implanting the preparation. In support of this approach, we are focused on developing technology that fulfills the vision associated with concepts like Fusionary™ and Disctoration™. Fusionary™ is a concept that combines a physician’s use of autologous BMC and substrates for achieving bony fusion, while Disctoration™ refers to a physician using autologous BMC and specialized delivery devices to aid in treating degenerative disc disease.

Celling Biosciences has always been committed to offering physicians the most innovative technology for processing bone marrow at their discretion. An important step on our path to innovation was taken when the ART21 ™ device technology was offered to physicians. The ART21 ™ platform greatly improved the ease of use, reliability and reduced sterile breaks for physicians who wanted to concentrate bone marrow.

OUR LEADERSHIP

Celling Biosciences was formed by a team of experts in science, medicine and engineering. Although their backgrounds are diverse, they are guided by a common philosophy: regenerative medicine offers infinite potential to transform the medical landscape and improve the lives of millions.

Kevin Dunworth

Kevin Dunworth

CEO & Founder

Steve Melchiode

Steve Melchiode

President

Hank Brown

Hank Brown

Executive Vice President

Science Team!

OUR SCIENTISTS

These are the people who keep us on the cutting edge of regenerative medicine every day.

Richard Suzuki, PhD

Richard Suzuki, PhD

Director of Biomaterials

Meghana Malur, PhD

Meghana Malur, PhD

Clinical Research Scientist